Results 271 to 280 of about 86,632 (376)
This work introduces a highly customizable granular hydrogel scaffold, designed from reactive microparticles through binary macromonomer microdroplet assembly, achieving a precise balance of mechanical strength and biological functionality. Abstract Engineering bioscaffolds with tailored architectures and optimized physicochemical properties remains a ...
Jing Zhang+11 more
wiley +1 more source
Red cell mass measurement is still useful for the management of myeloproliferative neoplasms. Comment to "Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes Myeloprolifératifs". [PDF]
Maaziz N, Girodon F.
europepmc +1 more source
ON THE STRUCTURE OF PROTEINS: CATTLE HEMOGLOBIN, EGG ALBUMIN, CATTLE FIBRIN, AND GELATIN
Max Bergmann, Carl Niemann
openalex +1 more source
Aided by FABP5, abnormally elevated asprosin in hepatocytes enters the nucleus, targets and inhibits PPARα binding to the CPT1A promoter, thereby suppressing FAO. Circulating asprosin exacerbates insulin resistance, collectively driving MASLD progression.
Yuan‐Yuan Yu+13 more
wiley +1 more source
Base editing HbS to HbG-Makassar improves hemoglobin function supporting its use in sickle cell disease. [PDF]
Kostamo Z+26 more
europepmc +1 more source
RATIO OF SICKLE-CELL ANEMIA HEMOGLOBIN TO NORMAL HEMOGLOBIN IN SICKLEMICS
Ibert C. Wells, Harvey A. Itano
openalex +1 more source
This study reveals that M2‐EVs mitigate periodontitis‐induced bone resorption by modulating neutrophil fate. Single‐cell RNA sequencing identified an Anxa1hi neutrophil subpopulation with pro‐reparative properties. M2‐EVs disrupt neutrophil maturation, promoting this subpopulation through key reprogramming genes (Acvrl1, Fpr2). These findings highlight
Yufei Yao+7 more
wiley +1 more source
Rapid preparation of bioactive composites for transforaminal lumbar interbody fusion. [PDF]
Ding B, Wang X, Zhao C, Zhao J.
europepmc +1 more source
Pancreatic cancer is a highly aggressive malignancy with limited treatment options. CLK4 regulates alternative splicing, contributing to cancer progression. This study establishes a computational model to identify CLK4 inhibitors, leading to compound 150441 (IC50: 21.4 nm).
Chun‐Lin Yang+13 more
wiley +1 more source